Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

4,003 public trials 391 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD

NCT00535366

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1249.1.32003 Boehringer Ingelheim Investigational Site Genk, Belgium
  • 1249.1.32001 Boehringer Ingelheim Investigational Site Ghent, Belgium
  • 1249.1.32002 Boehringer Ingelheim Investigational Site Hasselt, Belgium
  • 1249.1.32004 Boehringer Ingelheim Investigational Site Ostend, Belgium
View Trial Details
Completed

Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) Test

NCT01644734

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site 236 Andrychów, Poland
  • Boehringer Ingelheim Investigational Site 170 Bialystok, Poland
  • Boehringer Ingelheim Investigational Site 184 Bialystok, Poland
  • Boehringer Ingelheim Investigational Site 240 Bialystok, Poland
View all 247 locations
View Trial Details
Completed

The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01574651

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Dresden, Germany
View all 144 locations
View Trial Details
Completed

Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

NCT00523991

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.365.1003 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.365.1004 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.365.1098 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 205.365.1023 Boehringer Ingelheim Investigational Site Palo Alto, California, United States
View all 62 locations
View Trial Details
Completed

Tiotropium / Respimat One-Year Study

NCT00168844

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • Boehringer Ingelheim Investigational Site Pismo Beach, California, United States
  • Boehringer Ingelheim Investigational Site San Diego, California, United States
  • Boehringer Ingelheim Investigational Site Fort Collins, Colorado, United States
View all 72 locations
View Trial Details
Completed

Tiotropium / Respimat One-Year Study

NCT00168831

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Boehringer Ingelheim Investigational Site La Jolla, California, United States
  • Boehringer Ingelheim Investigational Site Long Beach, California, United States
  • Boehringer Ingelheim Investigational Site San Luis Obispo, California, United States
View all 76 locations
View Trial Details
Completed

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

NCT00144339

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.235.3779 Boehringer Ingelheim Investigational Site Anniston, Alabama, United States
  • 205.235.3785 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.235.3804 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 205.235.3795 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
View all 490 locations
View Trial Details

Related conditions